MARKER FOR THE DIAGNOSIS OF SUSCEPTIBILITY TO PROSTATE CANCER USING RETN GENE AND METHOD FOR PREDICTING AND ANALYZING SUSCEPTIBILITY TO PROSTATE CANCER USING THE SAME

摘要

PURPOSE: A marker for diagnosing prostate cancer susceptibility using RETN(resistin) gene is provided to diagnose risk of prostate cancer and predict susceptibility to prostate cancer. CONSTITUTION: A marker for diagnosing prostate cancer susceptibility contains polymorphic site of RETN gene. The polymorphic site of the RETN gene has 201th base of sequence number 1 in which C is substituted with G. A kit for diagnosing prostate cancer contains a primer for amplifying a polynucleotide containing 201th base of sequence number 1. The primer has sequences of sequence number 6 and 7. A method for predicting and determining prostate cancer susceptibility comprises: a step of collecting nucleic acid sample from a sample; a step of amplifying 201th base polymorphic site of sequence number 1 in the nucleic acid sample; and a step of determining amplified polymorphic site and analyzing risk of prostate cancer.